Annual Shareholders Equity
-$1.35 B
-$99.64 M-7.94%
31 December 2023
Summary:
BridgeBio Pharma annual stockholders equity is currently -$1.35 billion, with the most recent change of -$99.64 million (-7.94%) on 31 December 2023. During the last 3 years, it has fallen by -$483.84 million (-55.59%). BBIO annual shareholders equity is now -431.56% below its all-time high of $408.45 million, reached on 31 December 2019.BBIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$1.23 B
-$137.00 M-12.53%
30 September 2024
Summary:
BridgeBio Pharma quarterly stockholders equity is currently -$1.23 billion, with the most recent change of -$137.00 million (-12.53%) on 30 September 2024. Over the past year, it has increased by +$124.33 million (+9.18%). BBIO quarterly shareholders equity is now -367.52% below its all-time high of $459.76 million, reached on 30 September 2019.BBIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBIO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +9.2% |
| 3 y3 years | -55.6% | -41.3% |
| 5 y5 years | -431.6% | -401.1% |
BBIO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.6% | at low | -41.3% | +9.7% |
| 5 y | 5 years | -431.6% | at low | -401.1% | +9.7% |
| alltime | all time | -431.6% | at low | -367.5% | +9.7% |
BridgeBio Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.23 B(+12.5%) |
| June 2024 | - | -$1.09 B(+4.1%) |
| Mar 2024 | - | -$1.05 B(-22.5%) |
| Dec 2023 | -$1.35 B(+7.9%) | -$1.35 B(+12.1%) |
| Sept 2023 | - | -$1.21 B(-11.3%) |
| June 2023 | - | -$1.36 B(+11.1%) |
| Mar 2023 | - | -$1.23 B(-2.3%) |
| Dec 2022 | -$1.25 B(+44.1%) | -$1.25 B(+10.2%) |
| Sept 2022 | - | -$1.14 B(+11.0%) |
| June 2022 | - | -$1.03 B(-1.5%) |
| Mar 2022 | - | -$1.04 B(+19.6%) |
| Dec 2021 | -$870.41 M | -$870.41 M(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$743.40 M(+60.1%) |
| June 2021 | - | -$464.29 M(+17.5%) |
| Mar 2021 | - | -$395.29 M(-782.6%) |
| Dec 2020 | $57.91 M(-85.8%) | $57.91 M(-64.6%) |
| Sept 2020 | - | $163.76 M(-38.4%) |
| June 2020 | - | $265.76 M(-30.2%) |
| Mar 2020 | - | $380.71 M(-6.8%) |
| Dec 2019 | $408.45 M(+29.7%) | $408.45 M(-11.2%) |
| Sept 2019 | - | $459.76 M(-245.4%) |
| June 2019 | - | -$316.12 M(-225.4%) |
| Mar 2019 | - | $252.14 M(-19.9%) |
| Dec 2018 | $314.88 M(-642.7%) | $314.88 M |
| Dec 2017 | -$58.02 M | - |
FAQ
- What is BridgeBio Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly shareholders equity year-on-year change?
What is BridgeBio Pharma annual stockholders equity?
The current annual shareholders equity of BBIO is -$1.35 B
What is the all time high annual shareholders equity for BridgeBio Pharma?
BridgeBio Pharma all-time high annual stockholders equity is $408.45 M
What is BridgeBio Pharma quarterly stockholders equity?
The current quarterly shareholders equity of BBIO is -$1.23 B
What is the all time high quarterly shareholders equity for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly stockholders equity is $459.76 M
What is BridgeBio Pharma quarterly shareholders equity year-on-year change?
Over the past year, BBIO quarterly stockholders equity has changed by +$124.33 M (+9.18%)